To meet the space industry’s soaring demands, manufacturers of satellites, rockets, and other critical hardware need to focus on five priority areas.
Investments in food innovation aren’t scaling fast enough. But with the proper mechanisms and strong cross-sector collaboration among stakeholders, transformative and sustainable progress is possible.
Biopharma companies can leverage new sources of patient data and technology to create more personalized patient experiences that have the potential to deliver better health outcomes.
To harness the power of generative AI and keep up with the wave of constant innovation, CTOs need to rethink their company’s digital and organizational infrastructure.
The US biosimilars market is experiencing strong growth as regulations evolve and physician confidence in these products grows. But market patterns are changing.
To boost health outcomes and their bottom lines, some insurers are offering patients and providers incentives to choose treatments that have high clinical value.
Read BCG’s Latest Insights and Perspectives
Explore BCG’s Industries